<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969874</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/21/0023</org_study_id>
    <nct_id>NCT04969874</nct_id>
  </id_info>
  <brief_title>Remote Orthophonic Follow-up on Patients With Chronic Swallowing Disorders</brief_title>
  <acronym>E-CRIL_MAX</acronym>
  <official_title>Feasibility of at Home Remote Monitoring Following a Stay in Intensive Rehabilitation in Patients With Chronic Swallowing Disorders Caused by Treatment for Cancer of the Aero-digestive Tract: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ligue contre le cancer, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will assess the feasibility of monthly post rehabilitation remote monitoring, using&#xD;
      the &quot;MAX Educ&quot; webvision app, in patients with sequelae of aerodigestive cancer treatments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients included in the study will benefit from a monthly video follow-up via the WEB&#xD;
      tool &quot;MAX Educ&quot; during the first 6 months of their discharge from the rehabilitation center.&#xD;
      They will be contacted each month during 5 months by the CRIL speech therapist for an&#xD;
      interview (20 to 30 minutes).&#xD;
&#xD;
      The interview will take place in 2 stages; at first, a discussion phase, during which the&#xD;
      speech therapist will take simple news of the patient. The second phase, more formal, will be&#xD;
      the opportunity to collect the data necessary for the validation of the secondary endpoints.&#xD;
      To do this, the speech therapist will use the Deglutition Handicap Index (DHI) and an&#xD;
      interview grid.&#xD;
&#xD;
      The interview will be conducted using an interview sheet previously written by the project&#xD;
      team. The following elements will be discussed: the perceived swallowing handicap (DHI), the&#xD;
      instructions related to diet and their daily application, ongoing rehabilitation follow-ups,&#xD;
      notable events as well as his psycho-emotional experience in relation to said disorders.&#xD;
&#xD;
      After signing the consent and verifying the eligibility criteria, all patients will be&#xD;
      assessed upon discharge from the rehabilitation center by means of video swallowing&#xD;
      fluoroscopy, allowing the deglutition score to be established.&#xD;
&#xD;
      EORTC Quality of Life Questionnaire QLQ-30 and its annex H &amp; N35 and the DHI will also be&#xD;
      completed at the inclusion visit at T0.&#xD;
&#xD;
      They will then be monitored monthly by video from Month 1 to Month 5.&#xD;
&#xD;
      During the end of research visit at 6 months, all the patients included will be reviewed in&#xD;
      follow-up consultation with a doctor and a speech therapist within the intensive&#xD;
      rehabilitation center for laryngectomees (which corresponds to the standard follow-up) and&#xD;
      evaluated by video swallowing fluoroscopy. EORTC QLQ-30, EORTC QLQ-H &amp; N35 quality of life&#xD;
      questionnaires and the DHI will also have to be completed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Monocentric prospective longitudinal pilot study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patient attendance at monthly remote monitoring</measure>
    <time_frame>Month 6 : end of follow-up</time_frame>
    <description>Attendance will be evaluated by measuring the rate of patients who participated in at least 3 webvisions out of 5 and at the final visit in face-to-face consultation, compared to the number of patients included.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 0 : before follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 1 of follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 2 of follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 3 of follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 4 of follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 5 of follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>felt swallowing</measure>
    <time_frame>Month 6 of follow-up</time_frame>
    <description>The feeling of swallowing will be evaluated with the Deglutition Handicap Index (DHI), a swallowing handicap self-assessment questionnaire. ranking from 30 to 150, 30 corresponding to no handicap swallowing, and 150 being the worst handicap to swallow</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Deglutition</condition>
  <arm_group>
    <arm_group_label>remote follow-up</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients with chronic disorders on sequelae of anti-cancer treatments after an intensive rehabilitation stay will undergo 5 months of remote follow-up with speech therapists including questionnaires and interview</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Remote follow-up</intervention_name>
    <description>The feeling of swallowing will be assessed at the end of the stay at the rehabilitation center, which corresponds to the first visit, and then every month for 5 months during remote interviews and on discharge with the Deglutition Handicap Index (DHI), a self-assessment questionnaire for the swallowing handicap.&#xD;
The quality of life will be assessed at the firs visit and 6 months after using the EORTC QLQ 30 quality of life scale and the H&amp;N annex, a self-assessment questionnaire on the quality of life for people with cancer of the head and neck.&#xD;
The satisfaction of users and the interest of city health professionals in the use of the &quot;MAX Educ&quot; tool as part of a monthly monitoring will be collected via the TUQ questionnaire, through the MAX platform at Month 6.</description>
    <arm_group_label>remote follow-up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged 18 or over and treated for cancer of the upper aero-digestive tract:&#xD;
&#xD;
          -  Patient having spent a stay at the intensive rehabilitation center for laryngectomees&#xD;
&#xD;
          -  Patient with a medical diagnosis of swallowing disorders at risk of inhalation&#xD;
&#xD;
          -  Patient having the possibility of accessing a device allowing the use of the software&#xD;
             by video (smartphone, tablet and / or computer)&#xD;
&#xD;
          -  Informed consent signed by the patient.&#xD;
&#xD;
          -  Patient affiliated to a social security scheme or equivalent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Progressive neurological disease leading to cognitive disorders&#xD;
&#xD;
          -  Patient with guardianship, curators or legal protection&#xD;
&#xD;
          -  Inability to give consent&#xD;
&#xD;
          -  Patient participating in another research including an exclusion period still in&#xD;
             progress&#xD;
&#xD;
          -  Patient with speech therapy whose frequency is greater than 1 weekly session&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anais Galtier</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anais Galtier</last_name>
    <phone>05 67 77 18 01</phone>
    <email>galtier.a@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anais GALTIER</last_name>
      <phone>05 67 77 18 01</phone>
      <email>Galtier.a@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Cl√©mence DEVOUCOUX</last_name>
      <phone>05 67 77 14 61</phone>
      <email>Devoucoux.c@chu-toulouse.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>remote video follow-up</keyword>
  <keyword>speech therapy</keyword>
  <keyword>Aerodigestive cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

